Small Cell Lung Cancer 2025 x Dr. Stephen Liu Part 2
Two Onc Docs
00:00
Innovations in Small Cell Lung Cancer Treatment
This chapter explores Tarlatamab, a bispecific T-cell engager targeting DLL3 and CD3, showcasing its potential in treating small cell lung cancer. It discusses the drug's efficacy, safety challenges, and the importance of biomarker-driven personalized treatment strategies, as well as ongoing research to refine therapeutic options.
Transcript
Play full episode
